Vaccitech (VACC) Stock Highlights

3.04 | +0%

2023-12-07 18:45:38

Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.

Statistics

Range Today

2.85 3.15

Volume Today 3.51K

Range 1 Year

1.64 5.1

Volume 1 Year 54.08M

Range 3 Year

1.64 17.99

Volume 3 Year 99.29M

Range 10 Year

1.64 17.99

Volume 10 Year 99.29M

Highlights

Market Capitalization 192.73M (small)

Floating Shares 28.3M

Current Price 3.04

Price To Earnings -3.03

Price To Revenue -0.2

Price To Book 0.89

Earnings Per Share -1.45

Payout Ratio 0%

Performance

Latest 0%

1 Month -39.2%

3 Months +61.7%

6 Months +20.63%

1 Year +38.18%

3 Years -77.68%

5 Years -77.68%

10 Years -77.68%

Benchmarks

Market Capitalization

232 / 368

Gross Profits

0 / 278

Total Revenue

176 / 300

Total Rank

51 / 368

Free Cashflow

118 / 352

Performance 5 years

228 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.